Mecp2em1Hzo
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Mecp2em1Hzo |
| Name: |
methyl CpG binding protein 2; endonuclease-mediated mutation 1, Huda Y Zoghbi |
| MGI ID: |
MGI:7565284 |
| Synonyms: |
Mecp2G118E |
| Gene: |
Mecp2 Location: ChrX:73070198-73129296 bp, - strand Genetic Position: ChrX, 37.63 cM
|
| Alliance: |
Mecp2em1Hzo page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence, Hypomorph) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a glycine to glutamic acid substitution at amino acid 118 (p.G118E). This is a novel variant identified in a male with developmental delay, generalized hypotonia, motor planning difficulty and metatarsus adductus that developed seizures with age. Hemizygous males express RNA levels comparable to wild-type in the cortex but have an approximate 40% reduction in protein.
(J:343257)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mecp2 Mutation: |
46 strains or lines available
|
|
| Original: |
J:343257 Zhou J, et al., A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels. Genes Dev. 2023 Oct 1;37(19-20):883-900 |
| All: |
2 reference(s) |
|